Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 23982716)

1.

Modelling the efficiency of local versus central provision of intravenous thrombolysis after acute ischemic stroke.

McMeekin P, Gray J, Ford GA, Rodgers H, Price CI.

Stroke. 2013 Nov;44(11):3114-9. doi: 10.1161/STROKEAHA.113.001240. Epub 2013 Aug 27.

2.

Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.

Ehlers L, Andersen G, Clausen LB, Bech M, Kjølby M.

Stroke. 2007 Jan;38(1):85-9. Epub 2006 Nov 22.

3.

A citywide prehospital protocol increases access to stroke thrombolysis in Toronto.

Gladstone DJ, Rodan LH, Sahlas DJ, Lee L, Murray BJ, Ween JE, Perry JR, Chenkin J, Morrison LJ, Beck S, Black SE.

Stroke. 2009 Dec;40(12):3841-4. doi: 10.1161/STROKEAHA.108.540377. Epub 2009 Oct 29.

4.

Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.

Tan Tanny SP, Busija L, Liew D, Teo S, Davis SM, Yan B.

Stroke. 2013 Aug;44(8):2269-74. doi: 10.1161/STROKEAHA.113.001295. Epub 2013 Jun 18.

5.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

6.

Cost-effectiveness of optimizing acute stroke care services for thrombolysis.

Penaloza-Ramos MC, Sheppard JP, Jowett S, Barton P, Mant J, Quinn T, Mellor RM, Sims D, Sandler D, McManus RJ; Birmingham and Black Country Collaborations for Leadership in Applied Health Research and Care Investigators.

Stroke. 2014 Feb;45(2):553-62. doi: 10.1161/STROKEAHA.113.003216. Epub 2014 Jan 2.

7.

An observational study of patient characteristics associated with the mode of admission to acute stroke services in North East, England.

Price CI, Rae V, Duckett J, Wood R, Gray J, McMeekin P, Rodgers H, Portas K, Ford GA.

PLoS One. 2013 Oct 8;8(10):e76997. doi: 10.1371/journal.pone.0076997. eCollection 2013.

8.

Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.

Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, Royle P, Davidson P, Vale L, MacKenzie L.

Health Technol Assess. 2005 May;9(17):1-99, iii-iv. Review.

9.

Prehospital triage to primary stroke centers and rate of stroke thrombolysis.

Prabhakaran S, O'Neill K, Stein-Spencer L, Walter J, Alberts MJ.

JAMA Neurol. 2013 Sep 1;70(9):1126-32. doi: 10.1001/jamaneurol.2013.293.

PMID:
23817961
10.

Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.

Minnerup J, Wersching H, Ringelstein EB, Schilling M, Schäbitz WR, Wellmann J, Berger K.

Stroke. 2011 Oct;42(10):2838-43. doi: 10.1161/STROKEAHA.111.616565. Epub 2011 Aug 18.

11.

Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.

Earnshaw SR, McDade C, Chapman AM, Jackson D, Schwamm L.

Clin Ther. 2012 Jul;34(7):1544-58. doi: 10.1016/j.clinthera.2012.05.004. Epub 2012 Jun 12.

PMID:
22695225
12.

Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.

Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, Lewis S, Lindley R, Neilson A, Wardlaw J.

Stroke. 2004 Jun;35(6):1490-7. Epub 2004 Apr 22.

13.

Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.

Earnshaw SR, Jackson D, Farkouh R, Schwamm L.

Stroke. 2009 May;40(5):1710-20. doi: 10.1161/STROKEAHA.108.540138. Epub 2009 Mar 12.

14.

Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Rost NS, Smith EE, Pervez MA, Mello P, Dreyer P, Schwamm LH.

Circ Cardiovasc Qual Outcomes. 2012 May;5(3):314-20. doi: 10.1161/CIRCOUTCOMES.111.962829. Epub 2012 Apr 24.

15.
16.
17.

A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.

Kim AS, Nguyen-Huynh M, Johnston SC.

Stroke. 2011 Jul;42(7):2013-8. doi: 10.1161/STROKEAHA.110.606889. Epub 2011 Jun 2.

18.
19.

Systematic review of stroke thrombolysis service configuration.

Price CI, Clement F, Gray J, Donaldson C, Ford GA.

Expert Rev Neurother. 2009 Feb;9(2):211-33. doi: 10.1586/14737175.9.2.211. Review.

PMID:
19210196
20.

Acute ischemic stroke and thrombolysis location: comparing telemedicine and stroke center treatment outcomes.

Ionita CC, Sharma J, Janicke DM, Levy EI, Siddiqui AH, Agrawal S, Baker JG, Agopian E, Olson K, Hopkins LN.

Hosp Pract (1995). 2009 Dec;37(1):33-9. doi: 10.3810/hp.2009.12.252.

PMID:
20877169
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk